Volume 169: Issue 6
December 2013

Table of contents
Close contents    x
Free Content

Editorial

Why write? (Page 1173 - 1174)

0

Favourite Read & Respond

Commentaries

Following in the footsteps of D avid B arker: the association between extreme prematurity and atopic dermatitis risk (Page 1175 - 1176)

0

Favourite Read & Respond

Commentaries

Burning issues in the diagnosis of xeroderma pigmentosum (Page 1176 - 1176)

0

Favourite Read & Respond

Commentaries

Interpreting outcome measures and defining treatment success (Page 1177 - 1178)

0

Favourite Read & Respond

Commentaries

Research in Stevens‐Johnson syndrome/toxic epidermal necrolysis (TEN): a network of specialist TEN centres is needed to undertake effective clinical studies and therapeutic trials (Page 1177 - 1177)

0

Favourite Read & Respond

Commentaries

Biologic therapy for psoriasis: early response implies future success (Page 1178 - 1179)

0

Favourite Read & Respond

Review articles

Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta‐analysis (Page 1180 - 1187)

0

Favourite Read & Respond

Review articles

Lessons learned from gene expression profiling of cutaneous T ‐cell lymphoma (Page 1188 - 1197)

0

Favourite Read & Respond

Review articles

The interpretation of long‐term trials of biologic treatments for psoriasis: trial designs and the choices of statistical analyses affect ability to compare outcomes across trials (Page 1198 - 1206)

0

Favourite Read & Respond

Clinical and laboratory investigations

Reticular erythematous mucinosis: a review of patients’ characteristics, associated conditions, therapy and outcome in 25 cases (Page 1207 - 1211)

0

Favourite Read & Respond

Clinical and laboratory investigations

Expression of programmed death‐1 ( CD 279) in primary cutaneous B‐cell lymphomas with correlation to lymphoma entities and biological behaviour (Page 1212 - 1218)

0

Favourite Read & Respond

Clinical and laboratory investigations

Reliability of quantification measures of actinic keratosis (Page 1219 - 1222)

0

Favourite Read & Respond

Clinical and laboratory investigations

Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients (Page 1223 - 1232)

0

Favourite Read & Respond

Clinical and laboratory investigations

High‐frequency (20–50 MHz) ultrasonography of pseudoxanthoma elasticum skin lesions (Page 1233 - 1239)

0

Favourite Read & Respond

Clinical and laboratory investigations

Favourable prognostic role of regression of primary melanoma in AJCC stage I–II patients (Page 1240 - 1245)

0

Favourite Read & Respond

Dermatological surgery and lasers

Q ‐switched laser depigmentation in vitiligo, most effective in active disease (Page 1246 - 1251)

0

Favourite Read & Respond

Paediatric dermatology

Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol (Page 1252 - 1256)

0

Favourite Read & Respond

Paediatric dermatology

Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age (Page 1257 - 1264)

0

Favourite Read & Respond

Paediatric dermatology

Short‐ and long‐term outcome of linear morphoea in children (Page 1265 - 1271)

0

Favourite Read & Respond

Photobiology

Lifestyle factors including less cutaneous sun exposure contribute to starkly lower vitamin D levels in U . K . South Asians compared with the white population (Page 1272 - 1278)

0

Favourite Read & Respond

Photobiology

Patients with xeroderma pigmentosum complementation groups C , E and V do not have abnormal sunburn reactions (Page 1279 - 1287)

0

Favourite Read & Respond

Photobiology

T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge (Page 1288 - 1294)

0

Favourite Read & Respond

Therapeutics

The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C (Page 1295 - 1303)

0

Favourite Read & Respond

Therapeutics

The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre (Page 1304 - 1309)

0

Favourite Read & Respond

Concise communications

Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors (Page 1310 - 1313)

0

Favourite Read & Respond

Concise communications

First left–right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex (Page 1314 - 1318)

0

Favourite Read & Respond

Concise communications

Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor‐α therapy necessary? (Page 1319 - 1321)

0

Favourite Read & Respond

Concise communications

Identification of the first nonsense CDSN mutation with expression of a truncated protein causing peeling skin syndrome type B (Page 1322 - 1325)

0

Favourite Read & Respond

Concise communications

Translating Patient‐Oriented Eczema Measure ( POEM ) scores into clinical practice by suggesting severity strata derived using anchor‐based methods (Page 1326 - 1332)

0

Favourite Read & Respond

Concise communications

Q10‐triggered facial vitiligo (Page 1333 - 1336)

0

Favourite Read & Respond

Concise communications

Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate‐to‐severe plaque psoriasis (Page 1337 - 1341)

0

Favourite Read & Respond

Case reports

Molecular evidence of type 2 mosaicism in G orlin syndrome (Page 1342 - 1345)

0

Favourite Read & Respond

Case reports

Two cases of clear cell sarcoma with different clinical and genetic features: cutaneous type with BRAF mutation and subcutaneous type with KIT mutation (Page 1346 - 1352)

0

Favourite Read & Respond

Case reports

A new homozygous nonsense mutation in LAMA 3A underlying laryngo‐onycho‐cutaneous syndrome (Page 1353 - 1356)

0

Favourite Read & Respond

Correspondence

Re: Digital compression of facial arteries facilitates cutaneous nasal surgery (Page 1357 - 1357)

Media

bjd12464-sup-0001-video.mp4

0

Favourite Read & Respond

Correspondence

Resolution of the plantar hyperkeratosis of pachyonychia congenita during chemotherapy for Ewing sarcoma (Page 1357 - 1360)

0

Favourite Read & Respond

Correspondence

Dermatology training in the U.K.: does it reflect the changing demographics of our population? (Page 1360 - 1362)

0

Favourite Read & Respond

Correspondence

Evidence for a role of neural pathways in dermographism (Page 1362 - 1363)

0

Favourite Read & Respond

Correspondence

Strongyloidiasis complicating immunosuppression for pemphigus vulgaris (Page 1363 - 1364)

0

Favourite Read & Respond

Correspondence

Fashions change but tattoos are forever: time to regret (Page 1364 - 1366)

0

Favourite Read & Respond

Correspondence

Incidence of primary cutaneous T‐cell lymphoma in Wales (Page 1366 - 1367)

0

Favourite Read & Respond

Correspondence

Cushing syndrome and rebound generalized pustular psoriasis from C hinese herbs (Page 1367 - 1369)

0

Favourite Read & Respond

Correspondence

Annular telangiectatic perivascular angiomatosis: a paradoxical adverse event of propranolol (Page 1369 - 1371)

0

Favourite Read & Respond

Correspondence

Desmoplastic melanoma presenting with localized hair repigmentation (Page 1371 - 1373)

0

Favourite Read & Respond

News and Notices

News and Notices (Page 1374 - 1374)

0

Favourite Read & Respond

Close